Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DAIICHI SANKYO COMPANY, LIMITED

(4568)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DAIICHI SANKYO COMPANY, LIMITED
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
MT
10/25Daiichi Sankyo Company, Limited and AstraZeneca Announces Second Clinical Trial Collabo..
CI
10/21Daiichi Sankyo Announces Development Progress of mRNA COVID-19 Vaccine in Japan
CI
10/21SHIONOGI : Japan's Shionogi starts Phase II/III clinical trial for new COVID-19 vaccine
RE
10/18Nikkei 225 Edges Down 0.2% on Profit-Taking, Energy Outlook
MT
10/13PRESS RELEASE : Defence Therapeutics Inc.: DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO ..
DJ
10/11DAIICHI SANKYO : Corporate Governance Report
PU
10/05DAIICHI SANKYO : Astrazeneca - Enhertu granted Breakthrough Therapy Designation in US for ..
AQ
10/04Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca Receive Gra..
CI
10/04ASTRAZENECA : Daiichi Sankyo's Enhertu Gets US FDA Breakthrough Therapy Tag for Breast Can..
MT
10/04AstraZeneca Says FDA Granted Breakthrough-Therapy Designation for Cancer Treatment Enhe..
DJ
09/29DAIICHI SANKYO COMPANY, LIMITED : Ex-dividend day for interim dividend
FA
09/21Nikkei 225 Falls 2.2% on China Property Outlook
MT
09/20Japanese shares fall on Evergrande jitters; bargain-hunting limits losses
RE
09/20DAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72% vs. trast..
AQ
09/20DAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9% in patie..
AQ
09/20ASTRAZENECA : Touts Positive Survival Data for Cancer Therapies Imfinzi, Enhertu
MT
09/20DAIICHI SANKYO : Enhertu demonstrated clinically meaningful and durable response in patien..
AQ
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patien..
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Prolongs Survival in Mid-Stage Gastric Cancer Study
MT
09/18DAIICHI SANKYO : ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus T..
BU
09/18Daiichi Sankyo Company, Limited and AstraZeneca Announce Reduction of Risk of Disease P..
CI
09/18Daiichi Sankyo Company Demonstrated Robust and Durable Tumor Response of 54.9% in Patie..
CI
09/18Daiichi Sankyo Company, Limited and AstraZeneca announce ENHERTU® Demonstrated Clinical..
CI
09/17AstraZeneca Sees Positive Results for Enhertu Trial
DJ
09/17Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute, LLC Announce DS-73..
CI
09/16Japanese shares edge up as FOMO keeps rally alive
RE
09/16Daiichi Sankyo Company, Limited and AstraZeneca Announces That the First Patient Was Do..
CI
09/15China's biotech sector comes of age with big licensing deals, global ambitions
RE
09/07URAVAN MINERALS : Rises 20% as it Looks at Strategic Alternatives Because of Low Uranium P..
MT
08/30Daiichi Sankyo Company, Limited Announces Results from the Multinational, Randomized, C..
CI
08/20NIKKEI 225 : Declines 1% On Toyota, Pandemic Outlooks
MT
08/20Nikkei falls to 8-month low as Toyota drags peers, materials makers
RE
08/19Nikkei slides to 7-month low as Toyota drags peers, other cyclicals
RE
08/19Defence therapeutics selects the best 8 accumtm variants to optimize its adc therapeuti..
AQ
08/19Toyota drags Nikkei to 7-month low after output cut report
RE
08/18Japanese shares fall, struggle to shake off Delta variant fears
RE
08/18PRESS RELEASE : Defence therapeutics selects the best 8 accum(tm) variants to optimize its..
DJ
08/17NIKKEI 225 : Down 0.4% as Pandemic Undercuts Optimism
MT
08/12Interim Results for the Six Months Ended 30 June -2-
DJ
08/10LOGICBIO THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Highlights Recen..
AQ
08/10DAIICHI SANKYO : Enhertu significantly improved progression-free survival in DESTINY-Breas..
AQ
08/09ENHERTU® (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Progression-Free Surv..
CI
08/09ASTRAZENECA : Forxiga Nabs New EU Nod As Enhertu Logs Breast Cancer Win
MT
08/09ASTRAZENECA : Breast Cancer Drug Shown to Extend Lives Better Than Roche's Kadcyla in Phas..
MT
08/09DAIICHI SANKYO : ENHERTU® Significantly Improved Progression-Free Survival in DESTINY-Brea..
BU
07/30DAIICHI SANKYO : Consolidated Financial Results for the First Three Months of the Year End..
PU
07/30DAIICHI SANKYO : Top Management Presentation
PU
07/30DAIICHI SANKYO : Reference Data
PU
07/30Daiichi Sankyo Company, Limited Forecasts Dividend for the Second Quarter of Fiscal Yea..
CI
07/30Daiichi Sankyo Company, Limited Provides Dividend Guidance for the Year Ending March 31..
CI
07/30Daiichi Sankyo Company, Limited Provides Earnings Guidance for the Full Year Ending Mar..
CI
07/30Daiichi Sankyo Company, Limited Reports Consolidated Earnings Results for the First Qua..
CI
07/21Daiichi Sankyo Completes Issue of Shares in Stock Compensation Program
MT
07/08ASTRAZENECA : Daiichi Sankyo, AstraZeneca's Late-Stage Trial of Enhertu for Gastric Cancer..
MT
07/08ASTRAZENECA : Daiichi Sankyo Late-Stage Trial of Enhertu for Gastric Cancer Doses First Pa..
MT
07/08Daiichi Sankyo Company, Limited and AstraZeneca Announces DESTINY-Gastric04 Head-to-Hea..
CI
07/02Nikkei ends higher on Sony, Toyota boost; posts weekly drop on virus woes
RE
07/01TOKYO ELECTRIC POWER INCORPORATED : Olympics-Japan PM says no spectators possible as Samoa..
RE
06/23Daiichi Sankyo to Issue Common Stocks to Employees Under Share Compensation Plan
MT
06/22DAIICHI SANKYO : Corporate Governance Report
PU
06/15Japan's Daiichi Sankyo halts trials of existing drug for COVID-19 treatment
RE
06/14Japanese shares inch higher, Toshiba up after ouster of board directors
RE
06/13Japanese shares track Wall Street higher, gains capped as investors await Fed's stateme..
RE
06/11Daiichi Sankyo Company, Limited Announces New Data for valemetostat
CI
06/11Daiichi Sankyo Announces That Delytact® Oncolytic Virus G47 Approves in Japan for Treat..
CI
06/08Nikkei 225 Slips 0.2% on Inflation Outlook, Asian Market Softness
MT
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/04Daiichi Sankyo Company, Limited Announces Patritumab Deruxtecan Data at ASCO Demonstrat..
CI
06/04Daiichi Sankyo Company, Limited Announces New Data of Patritumab Deruxtecan (HER3-Dxd)
CI
06/02Japan shares rally as reopening hopes boosts travel, real estate firms
RE
06/01Japan shares rally as reopening hopes boosts travel, real estate firms
RE
05/31ETRION : Sells Niigata Solar Project for $57 Million, Expects Further Disposals in Coming ..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on DAIICHI SANKYO COMPANY, LIMITED
10/29/21